Correlation Engine 2.0
Clear Search sequence regions

  • cancer (1)
  • chimeras (4)
  • diseases and (3)
  • humans (1)
  • protein human (1)
  • proteolysis (2)
  • SYK (13)
  • target drug (1)
  • therapies (2)
  • Sizes of these terms reflect their relevance to your search.

    Spleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase. The dysregulation of SYK is closely related to the occurrence and development of allergic diseases, autoimmune diseases and cancer. SYK has become an attractive target for drug discovery due to its important biological functions. This article reviews the biological function of SYK, the relationship between SYK and disease, and therapies targeting SYK. In addition, inspired by new technologies such as proteolysis targeting chimeras (PROTACs) and phosphatase recruiting chimeras (PHORCs), we propose the development of new therapeutic approaches for targeting SYK, such as SYK PROTACs and SYK PHORCs, which may overcome deficiencies of existing methods. Copyright © 2023 Elsevier Ltd. All rights reserved.


    Zhaozhao Wang, Shu Qu, Jiahao Yuan, Wen Tian, Jinglei Xu, Rui Tao, Shilong Sun, Tao Lu, Weifang Tang, Yong Zhu. Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK). Bioorganic & medicinal chemistry. 2023 Dec 15;96:117514

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37984216

    View Full Text